Porous electrolytic polymer cryogels for enhanced electrical collapsibility
The invention provides cryogels whose porosity, pore size, pore connectivity, swelling agent concentration, and/or specific volume undergoes a change from a first value to a second value in response to an electrical stimulus. The cryogels have interconnected macropores which greatly enhance their ability to rapidly undergo volumetric collapse when subjected to moderate electric fields. The cryogels of the invention can be easily integrated into arrays capable of rapid configurational and chromatic optical modulations, and when loaded with drugs, are able to coordinate the delivery profile of multiple drugs. The cryogel can be prepared by polymerizing an aqueous solution of charged monomers and cross-linker monomers at a temperature below the freezing temperature of the solvent.
1. A macroporous electro-responsive cryogel,
comprising charged monomers and cross-linker monomers in a ratio of about 8:1 to about 7:0.5 or a ratio of about 8:0.5 to about 40:1 by weight, volume or mole,
wherein the cryogel is prepared by polymerizing an aqueous solution of the charged monomers and the cross-linker monomers by freezing at a temperature below the freezing temperature of the aqueous solvent,
wherein the charged monomers are about 4% to about 11% by weight, volume or mol of the aqueous solution, and
wherein the cryogel is capable of volumetric collapse in response to an electrical stimulus.
2. The macroporous electro-responsive cryogel of claim 1 , wherein the charged monomers are selected from the group consisting of acrylic acid (AAc), methacrylic acid, 3-(acrylamido)phenylboronic acid and derivatives, and any combinations thereof.
3. The macroporous electro-responsive cryogel of claim 1 , wherein the cross-linker monomers are selected from the group consisting of N,N′-methylenebis-acrylamide (BA), polyethyleneglycol di(meth)acrylate (PEG-DM), and any combination thereof.
4. The macroporous electro-responsive cryogel of claim 1 , wherein the charged monomers are acrylic acid and the cross-linker monomers are N,N′-methylenebis-acrylamide or polyethyleneglycol di(meth)acrylate.
5. The macroporous electro-responsive cryogel of claim 1 , wherein the charged monomers are about 4% to about 9% by weight, volume or mol of the aqueous solution.
6. The macroporous electro-responsive cryogel of claim 1 , wherein the cross-linker monomers are from 0.01% to 10% by weight, volume or mol of the aqueous solution.
7. The macroporous electro-responsive cryogel of claim 1 , wherein the aqueous solution further comprises uncharged monomers.
8. The macroporous electro-responsive cryogel of claim 7 , wherein the uncharged monomers are selected from the group consisting of N-substituted and non-substituted acrylamides; N-substituted and non-substituted (meth)acrylamides; N-alkyl substituted N-vinylamides; Hydroxyalkyl (meth)acrylates; vinylacetate; alkylethers of vinyl alcohols; styrene and ring substituted styrene derivatives; vinyl monomers; and any combinations thereof.
9. The macroporous electro-responsive cryogel of claim 7 , wherein the charged monomers are acrylic acid, the uncharged monomers are acrylamide, and the cross-linker monomers are N,N′-methylenebis-acrylamide or polyethyleneglycol di(meth)acrylate.
10. The macroporous electro-responsive cryogel of claim 7 , wherein the uncharged monomers are about 0.5% to about 5% by weight, volume or mol of the aqueous solution.
11. The macroporous electro-responsive cryogel of claim 7 , wherein the ratio of charged monomers to uncharged monomers is from about 5:0.5 to about 1:1 by weight, volume or mol.
12. The macroporous electro-responsive cryogel of claim 1 , wherein the aqueous solvent is selected from the group consisting of water and mixtures of water and water-miscible organic solvents.
13. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel further comprises a compound selected from the group consisting of a small organic molecule; a small inorganic molecule; a saccharine; an oligosaccharide; a polysaccharide; a biological macromolecule; a nucleic acid; a nucleic acid analog and derivative; an extract made from biological materials; an animal tissue; a naturally occurring or synthetic composition; and any combinations thereof.
14. The macroporous electro-responsive cryogel of claim 13 , wherein the compound is a therapeutic agent, a biological cell, or a detectable molecule.
15. The macroporous electro-responsive cryogel of claim 1 , wherein the polymerization reaction is carried out at a temperature at least 5° C. below the freezing temperature of the aqueous solvent.
16. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel comprises pores having a mean pore diameter in a range of about 0.01 μm to 1000 μm.
17. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel has a porosity of 0.1 to 0.99.
18. A method for preparation of an electro-responsive cryogel of claim 1 , the method comprising: polymerizing an aqueous solution of charged monomers and cross-linker monomers under freezing at temperature below the freezing temperature of aqueous solvent.
19. A method for controlling the release of a bioactive agent, the method comprising: (a) providing a macroporous electro-responsive cryogel of claim 1 , wherein the cryogel comprises the bioactive agent; and (b) inducing a change in porosity, pore size, pore connectivity, swelling agent concentration, and/or specific volume of the composition via an electrical stimulus to control the release of the bioactive agent.
20. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel is capable of collapsing within tens of seconds in response to the electrical stimulus.
21. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel is capable of collapsing to less than 5% of the original area in response to the electrical stimulus.
22. The macroporous electro-responsive cryogel of claim 1 , wherein the cryogel is capable of collapsing reversibly in response to the electrical stimulus.
23. The macroporous electro-responsive cryogel of claim 13 , wherein the cryogel is capable of delivering the compound in a triggered and stimulus-proportioned manner.
24. The macroporous electro-responsive cryogel of claim 11 , wherein the ratio of charged monomers to uncharged monomers is from about 8:4 to about 1:1 by weight, volume or mol.
25. The macroporous electro-responsive cryogel of claim 13 , wherein the compound is a therapeutic agent.